- Home
- BRTX vs UCAR Comparison
BRTX vs UCAR Comparison
Compare BRTX & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- UCAR
- Stock Information
- Founded
- BRTX 1997
- UCAR 2013
- Country
- BRTX United States
- UCAR China
- Employees
- BRTX N/A
- UCAR N/A
- Industry
- BRTX Managed Health Care
- UCAR Retail-Auto Dealers and Gas Stations
- Sector
- BRTX Health Care
- UCAR Consumer Discretionary
- Exchange
- BRTX Nasdaq
- UCAR Nasdaq
- Market Cap
- BRTX 12.6M
- UCAR 13.3M
- IPO Year
- BRTX N/A
- UCAR 2023
- Fundamental
- Price
- BRTX $1.61
- UCAR $3.86
- Analyst Decision
- BRTX Strong Buy
- UCAR
- Analyst Count
- BRTX 1
- UCAR 0
- Target Price
- BRTX $18.00
- UCAR N/A
- AVG Volume (30 Days)
- BRTX 253.7K
- UCAR 52.7K
- Earning Date
- BRTX 08-12-2025
- UCAR 07-07-2025
- Dividend Yield
- BRTX N/A
- UCAR N/A
- EPS Growth
- BRTX N/A
- UCAR N/A
- EPS
- BRTX N/A
- UCAR N/A
- Revenue
- BRTX $391,000.00
- UCAR $6,067,871.00
- Revenue This Year
- BRTX $391.52
- UCAR N/A
- Revenue Next Year
- BRTX $3.50
- UCAR N/A
- P/E Ratio
- BRTX N/A
- UCAR N/A
- Revenue Growth
- BRTX 161.54
- UCAR 124.09
- 52 Week Low
- BRTX $1.21
- UCAR $2.30
- 52 Week High
- BRTX $2.55
- UCAR $9.43
- Technical
- Relative Strength Index (RSI)
- BRTX 46.78
- UCAR 58.97
- Support Level
- BRTX $1.57
- UCAR $3.53
- Resistance Level
- BRTX $1.72
- UCAR $4.32
- Average True Range (ATR)
- BRTX 0.13
- UCAR 0.39
- MACD
- BRTX -0.01
- UCAR 0.04
- Stochastic Oscillator
- BRTX 20.65
- UCAR 58.17
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.